114 related articles for article (PubMed ID: 1200651)
1. Mechlorethamine in psoriasis. Further attempts to induce immunological tolerance.
Breza TS; Kechijian P; Taylor JR
Arch Dermatol; 1975 Nov; 111(11):1438-9. PubMed ID: 1200651
[TBL] [Abstract][Full Text] [Related]
2. Failure to induce tolerance to mechlorethamine hydrochloride.
Leshaw S; Simon RS; Bear RL
Arch Dermatol; 1977 Oct; 113(10):1406-8. PubMed ID: 911169
[TBL] [Abstract][Full Text] [Related]
3. Intravenous desensitization to mechlorethamine in patients with psoriasis.
Pariser DM; Childers RC; Kechijian P; Halprin KM; Taylor JR
Arch Dermatol; 1976 Aug; 112(8):1113-4. PubMed ID: 952529
[TBL] [Abstract][Full Text] [Related]
4. PUVA therapy prevents sensitization to mechlorethamine in patients with psoriasis.
Mauduit G; Silvestre O; Thivolet J
Br J Dermatol; 1985 Nov; 113(5):515-21. PubMed ID: 2933055
[TBL] [Abstract][Full Text] [Related]
5. Topical mechlorethamine for psoriasis. An attempt to avoid the development of sensitization by the use of a topical tolerogenic schedule.
Price NM
Int J Dermatol; 1979 Jun; 18(5):390-3. PubMed ID: 468460
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis therapy. The effect of UV radiation on sensitization to mechlorethamine.
Nusbaum BP; Edwards EK; Horwitz SN; Frost P
Arch Dermatol; 1983 Feb; 119(2):117-21. PubMed ID: 6337558
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with psoriasis by PUVA therapy and mechlorethamine.
Mauduit G; Salle G; Schott AM; Thivolet J
Br J Dermatol; 1986 Aug; 115 Suppl 31():82-5. PubMed ID: 3741804
[No Abstract] [Full Text] [Related]
8. Topically applied mechlorethamine in the treatment of psoriasis.
Mandy S; Taylor JR; Halprin K
Arch Dermatol; 1971 Mar; 103(3):272-6. PubMed ID: 5548274
[No Abstract] [Full Text] [Related]
9. Topical mustine hydrochloride and psoriasis: a follow-up study.
Purdy MJ
Australas J Dermatol; 1975 Apr; 16(1):13-6. PubMed ID: 1212121
[No Abstract] [Full Text] [Related]
10. Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity.
Constantine VS; Fuks ZY; Farber EM
Arch Dermatol; 1975 Apr; 111(4):484-8. PubMed ID: 1122150
[TBL] [Abstract][Full Text] [Related]
11. Topical mustine hydrochloride and psoriasis.
Purdy MJ
Australas J Dermatol; 1973 Aug; 14(2):68-72. PubMed ID: 4759451
[No Abstract] [Full Text] [Related]
12. Topical therapy of psoriasis with mechlorethamine.
Zackheim HS; Arnold JE; Farber EM; Cox AJ
Arch Dermatol; 1972 May; 105(5):702-6. PubMed ID: 5026678
[No Abstract] [Full Text] [Related]
13. Treatment of psoriasis with topical nitrogen mustard.
Handler RM; Medansky RS
Int J Dermatol; 1979 Nov; 18(9):758-61. PubMed ID: 511440
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of psoriasis by topical application of mechlorethamine. 118 reports].
Revuz J; Mathoret C; Veret G; Touraine R
Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):653-8. PubMed ID: 138380
[No Abstract] [Full Text] [Related]
15. The treatment of mycosis fungoides with ointment-based mechlorethamine.
Price NM; Deneau DG; Hoppe RT
Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet light treatment delays contact sensitization to nitrogen mustard.
Halprin KM; Comerford M; Presser SE; Taylor JR
Br J Dermatol; 1981 Jul; 105(1):71-6. PubMed ID: 7259980
[TBL] [Abstract][Full Text] [Related]
17. Failure to induce immune tolerance to nitrogen mustard. Intravenous administration preceding topical use in patients with proriasis.
Baer RL; Michaelides P; Prestia AE
J Invest Dermatol; 1972 Jan; 58(1):1-4. PubMed ID: 5009128
[No Abstract] [Full Text] [Related]
18. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G
Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
Vonderheid EC; Ekbote SK; Kerrigan K; Kalmanson JD; Van Scott EJ; Rook AH; Abrams JT
J Invest Dermatol; 1998 Jun; 110(6):946-50. PubMed ID: 9620303
[TBL] [Abstract][Full Text] [Related]
20. Topical mechlorethamine therapy for mycosis fungoides.
Price NM; Constantine VS; Hoppe RT; Fuks ZY; Farber EM
Br J Dermatol; 1977 Nov; 97(5):547-50. PubMed ID: 588466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
